ECM
ASXC

ExodusPoint Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

ExodusPoint Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22,476
Closed -$15K – 2337
2023
Q1 		$15K Buy
+22,476
New +$15.2K ﹤0.01% 1694
2021
Q2 		– Sell
-56,955
Closed -$185K – 2921
2021
Q1 		$185K Buy
+56,955
New +$206K ﹤0.01% 1890

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ExodusPoint Capital Management's ASXC Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q2 2023, closing a stake of 22,476 shares — an estimated $15K sold.

ExodusPoint Capital Management first reported a position in ASXC in Q1 2021 and held it in 2 quarters. The position peaked at $185K in Q1 2021. 80 funds tracked by Wall St. Rank hold ASXC as of Q2 2023.

  • ExodusPoint Capital Management reported no remaining Asensus Surgical, Inc. position as of Q2 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 22,476 Asensus Surgical, Inc. shares in Q2 2023, an estimated $15K.
  • ExodusPoint Capital Management first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 2 quarters.
  • ExodusPoint Capital Management's Asensus Surgical, Inc. position peaked at $185K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.